Literature DB >> 8282250

Peptic ulcer, cimetidine, and motor neurone disease--a record linkage study.

M P Vessey1, M J Goldacre, V Seagroatt, D Yeates.   

Abstract

A previous cohort study suggested that there might be an association between use of cimetidine and motor neurone disease. The Oxford Record Linkage Study was used to explore this hypothesis. In the analysis the presence of a peptic ulcer in patients after 1976 was taken as a proxy for cimetidine (and ranitidine) use. The past history of 540 patients with motor neurone disease in this period was compared with that of 1370 patients with multiple sclerosis (neurological controls) and over 240,000 control patients with a variety of other conditions. Among those with motor neurone disease, five had been previously admitted to hospital with peptic ulcer in comparison with an expected number of 7.4 (morbidity ratio 0.68, 95% confidence interval: 0.2 to 1.6). The corresponding figures for those with multiple sclerosis were 12 and 9.7 respectively (morbidity ratio 1.24, 95% confidence interval: 0.6 to 2.2). This study provides some evidence against the possibility that cimetidine (and ranitidine) are related to motor neurone disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8282250      PMCID: PMC1374457          DOI: 10.1136/gut.34.12.1660

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  3 in total

1.  Postmarketing surveillance of the safety of cimetidine: 10 year mortality report.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; R F Logan; K R Paterson; M P Vessey
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

2.  Risk factors in motor neuron disease: a case-control study.

Authors:  A Chió; P Meineri; A Tribolo; D Schiffer
Journal:  Neuroepidemiology       Date:  1991       Impact factor: 3.282

3.  Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.